Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Hypersensitivity Reaction

  Free Subscription


Articles published in J Am Acad Dermatol

Retrieve available abstracts of 90 articles:
HTML format
Text format



Single Articles


    March 2018
  1. FREEMYER B, Drozd B, Suarez A
    A cross-sectional study of YouTube videos about atopic dermatitis.
    J Am Acad Dermatol. 2018;78:612-613.
    PubMed     Text format    


    February 2018
  2. GUTTMAN-YASSKY E, Silverberg JI, Nemoto O, Forman SB, et al
    Baricitinib in adult patients with moderate-to-severe atopic dermatitis: a phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study.
    J Am Acad Dermatol. 2018 Feb 1. pii: S0190-9622(18)30129.
    PubMed     Text format     Abstract available


    January 2018
  3. SIMPSON EL, Flohr C, Eichenfield LF, Bieber T, et al
    Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE).
    J Am Acad Dermatol. 2018 Jan 15. pii: S0190-9622(18)30102.
    PubMed     Text format     Abstract available


  4. GUTTMAN-YASSKY E, Brunner PM, Neumann AU, Khattri S, et al
    Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial.
    J Am Acad Dermatol. 2018 Jan 15. pii: S0190-9622(18)30101.
    PubMed     Text format     Abstract available


  5. HE A, Feldman SR, Fleischer AB Jr.
    An assessment of the use of antihistamines in the management of atopic dermatitis.
    J Am Acad Dermatol. 2018 Jan 6. pii: S0190-9622(18)30020.
    PubMed     Text format     Abstract available


  6. ST JOHN J, Vedak P, Garza-Mayers AC, Hoang MP, et al
    Location of skin lesions in Henoch-Schonlein purpura and its association with significant renal involvement.
    J Am Acad Dermatol. 2018;78:115-120.
    PubMed     Text format     Abstract available


  7. MITTAL L, Zhang L, Feng R, Werth VP, et al
    Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study.
    J Am Acad Dermatol. 2018;78:100-106.
    PubMed     Text format     Abstract available


    December 2017
  8. BONCHAK JG, Swerlick RA
    Emerging Therapies for Atopic Dermatitis: TRPV1 Antagonists.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32825.
    PubMed     Text format     Abstract available


  9. YANES DA, Mosser-Goldfarb JL
    Emerging Therapies for Atopic Dermatitis: The Prostaglandin/Leukotriene Pathway.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32822.
    PubMed     Text format     Abstract available


  10. HAMANN CR, Thyssen JP
    Monoclonal Antibodies Against IL-13 and IL-31RA in Development for Atopic Dermatitis.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32819.
    PubMed     Text format     Abstract available


  11. VAKHARIA PP, Silverberg JI
    New Therapies for Atopic Dermatitis: Additional Treatment Classes.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32826.
    PubMed     Text format     Abstract available


  12. TIDWELL WJ, Fowler JF Jr
    T-Cell Inhibitors for Atopic Dermatitis.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32821.
    PubMed     Text format     Abstract available


  13. COTTER DG, Schairer D, Eichenfield L
    Emerging Therapies for Atopic Dermatitis: Jak Inhibitors.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32820.
    PubMed     Text format     Abstract available


  14. ZIRWAS MJ
    The Future is Finally Here: Advances in the Treatment of Atopic Dermatitis.
    J Am Acad Dermatol. 2017 Dec 14. pii: S0190-9622(17)32827.
    PubMed     Text format    


  15. FAINA V, Paolino G, Bavastrelli M, Calvieri S, et al
    Classification of cutaneous manifestations in patients with non-celiac gluten sensitivity (NCGS) and wheat allergy (WA).
    J Am Acad Dermatol. 2017 Dec 13. pii: S0190-9622(17)32811.
    PubMed     Text format    


    November 2017
  16. THYSSEN JP, Skov L, Egeberg A
    Cause specific mortality in adults with atopic dermatitis.
    J Am Acad Dermatol. 2017 Nov 1. pii: S0190-9622(17)32590.
    PubMed     Text format     Abstract available


  17. RICKSTREW J, Wang T, Liu D, Rajpara A, et al
    Mitigation or prevention of mild hair dye contact dermatitis after pretreatment with clobetasol foam.
    J Am Acad Dermatol. 2017;77:e129.
    PubMed     Text format    


  18. LAM BD, Miller MM, Sutton AV, Peng D, et al
    Vancomycin and DRESS: A retrospective chart review of 32 cases in Los Angeles, California.
    J Am Acad Dermatol. 2017;77:973-975.
    PubMed     Text format    


    October 2017
  19. FISHBEIN AB, Mueller K, Kruse L, Boor P, et al
    Sleep disturbance in children with moderate/severe atopic dermatitis: A case-control study.
    J Am Acad Dermatol. 2017 Oct 28. pii: S0190-9622(17)32306.
    PubMed     Text format     Abstract available


  20. BOOZALIS E, Patel S
    "Allergen of the Year" alkyl glucoside is an ingredient in top-selling sunscreens and facial moisturizers.
    J Am Acad Dermatol. 2017 Oct 14. pii: S0190-9622(17)32539.
    PubMed     Text format    


  21. YU S, Drucker AM, Lebwohl M, Silverberg JI, et al
    A systematic review of safety and efficacy of systemic corticosteroids in atopic dermatitis.
    J Am Acad Dermatol. 2017 Oct 12. pii: S0190-9622(17)32533.
    PubMed     Text format     Abstract available


  22. ECKERT L, Gupta S, Amand C, Gadkari A, et al
    The burden of atopic dermatitis in US adults: Health care resource utilization data from the 2013 National Health and Wellness Survey.
    J Am Acad Dermatol. 2017 Oct 7. pii: S0190-9622(17)32181.
    PubMed     Text format     Abstract available


  23. FLEMING P, Drucker AM
    Risk of Infection in Patients with Atopic Dermatitis Treated with Dupilumab: A Meta-Analysis of Randomized Controlled Trials.
    J Am Acad Dermatol. 2017 Oct 4. pii: S0190-9622(17)32457.
    PubMed     Text format     Abstract available


  24. KONG BY, Immaneni S, Paller AS, Xu S, et al
    Potential impact of biologics and emerging therapies for psoriasis and atopic dermatitis on future fertility: Reassurance to patients but more data are needed.
    J Am Acad Dermatol. 2017;77:758-763.
    PubMed     Text format    


  25. SILVERBERG JI, Hsu DY, Brieva J, Silverberg NB, et al
    Reply to: "Prognosis and management of Stevens-Johnson syndrome and toxic epidermal necrolysis".
    J Am Acad Dermatol. 2017;77:e119.
    PubMed     Text format    


  26. SCHNEIDER JA, Cohen PR
    Prognosis and management of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    J Am Acad Dermatol. 2017;77:e117.
    PubMed     Text format    


  27. HSU CY, Lee WR, Shih YH
    Recalcitrant chronic leg ulcer: An indication for patch testing for hydrocolloid dressing.
    J Am Acad Dermatol. 2017;77:e97-e98.
    PubMed     Text format    


  28. CHANSKY PB, Wanat K, Pappas-Taffer L, Rosenbach M, et al
    A cross-sectional survey of voriconazole prescribers: Assessing current practice and knowledge of cutaneous side effects.
    J Am Acad Dermatol. 2017;77:769-770.
    PubMed     Text format    


    September 2017
  29. BELUM VR, Marchetti MA, Dusza SW, Cercek A, et al
    A prospective, randomized, double-blinded, split-face/chest study of prophylactic topical dapsone 5% gel versus moisturizer for the prevention of cetuximab-induced acneiform rash.
    J Am Acad Dermatol. 2017;77:577-579.
    PubMed     Text format    


    August 2017
  30. EICHENFIELD LF, Call RS, Forsha DW, Fowler J Jr, et al
    Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis.
    J Am Acad Dermatol. 2017 Aug 17. pii: S0190-9622(17)31814.
    PubMed     Text format     Abstract available


  31. WAN J, Mitra N, Hoffstad OJ, Gelfand JM, et al
    Variations in risk of asthma and seasonal allergies between early- and late-onset pediatric atopic dermatitis: A cohort study.
    J Am Acad Dermatol. 2017 Aug 14. pii: S0190-9622(17)31817.
    PubMed     Text format     Abstract available


  32. SIMPSON EL, Bruin-Weller M, Flohr C, Ardern-Jones MR, et al
    When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council.
    J Am Acad Dermatol. 2017 Aug 10. pii: S0190-9622(17)31944.
    PubMed     Text format     Abstract available


  33. CHEN TJ, Chung WH, Chen CB, Hui RC, et al
    Methotrexate-induced epidermal necrosis: A case series of 24 patients.
    J Am Acad Dermatol. 2017;77:247-255.
    PubMed     Text format     Abstract available


    July 2017
  34. ABROUK M, Farahnik B, Zhu TH, Nakamura M, et al
    Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses.
    J Am Acad Dermatol. 2017;77:177-180.
    PubMed     Text format    


  35. OLIVER B, Free R, Aires D
    Preapplication of white petroleum jelly to adjacent skin to prevent aluminum chloride-induced irritant dermatitis.
    J Am Acad Dermatol. 2017;77:e7.
    PubMed     Text format    


    June 2017
  36. ECKERT L, Gupta S, Amand C, Gadkari A, et al
    Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: An analysis using the National Health and Wellness Survey.
    J Am Acad Dermatol. 2017 Jun 9. pii: S0190-9622(17)30506.
    PubMed     Text format     Abstract available


  37. THYSSEN JP, Toft PB, Halling-Overgaard AS, Gislason GH, et al
    Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis.
    J Am Acad Dermatol. 2017 Jun 7. pii: S0190-9622(17)30360.
    PubMed     Text format     Abstract available


  38. SHAHWAN KT, Kimball AB
    Itch intensity in moderate-to-severe plaque psoriasis versus atopic dermatitis: A meta-analysis.
    J Am Acad Dermatol. 2017;76:1198-1200.
    PubMed     Text format    


  39. CORCIMARU A, Morrell DS, Burkhart CN
    The Internet for patient education on atopic dermatitis: Friend or foe?
    J Am Acad Dermatol. 2017;76:1197-1198.
    PubMed     Text format    


    May 2017
  40. SILVERBERG JI, Simpson EL
    Reply to: "Heterogeneity of data included in meta-analysis on persistence of atopic dermatitis alters interpretation".
    J Am Acad Dermatol. 2017;76:e183-e184.
    PubMed     Text format    


  41. MARGOLIS DJ, Mitra N
    Heterogeneity of data included in meta-analysis on persistence of atopic dermatitis changes interpretation.
    J Am Acad Dermatol. 2017;76:e181.
    PubMed     Text format    


  42. SILVERBERG JI, Simpson EL
    Reply to: "Conclusions about atopic dermatitis persistence might be premature".
    J Am Acad Dermatol. 2017;76:e179.
    PubMed     Text format    


  43. ABUABARA K, Langan SM, Yu AM
    Conclusions about atopic dermatitis persistence might be premature.
    J Am Acad Dermatol. 2017;76:e177-e178.
    PubMed     Text format    


  44. RAMIREZ F, Chren MM, Botto N
    A review of the impact of patch testing on quality of life in allergic contact dermatitis.
    J Am Acad Dermatol. 2017;76:1000-1004.
    PubMed     Text format    


  45. HSU DY, Brieva J, Silverberg NB, Paller AS, et al
    Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States.
    J Am Acad Dermatol. 2017;76:811-817.
    PubMed     Text format     Abstract available


  46. LARSABAL M, Marti A, Jacquemin C, Rambert J, et al
    Vitiligo-like lesions occurring in patients receiving anti-programmed cell death-1 therapies are clinically and biologically distinct from vitiligo.
    J Am Acad Dermatol. 2017;76:863-870.
    PubMed     Text format     Abstract available


    April 2017
  47. THYSSEN JP, Skov L, Hamann CR, Gislason GH, et al
    Assessment of major comorbidities in adults with atopic dermatitis using the Charlson comorbidity index.
    J Am Acad Dermatol. 2017 Apr 6. pii: S0190-9622(17)30123.
    PubMed     Text format     Abstract available


  48. HAMANN CR, Hamann D, Egeberg A, Johansen JD, et al
    Association between atopic dermatitis and contact sensitization: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2017 Apr 6. pii: S0190-9622(17)30152.
    PubMed     Text format     Abstract available


  49. SHREBERK-HASSIDIM R, Ramot Y, Zlotogorski A
    Janus kinase inhibitors in dermatology: A systematic review.
    J Am Acad Dermatol. 2017;76:745-753.
    PubMed     Text format     Abstract available


  50. DAMSKY W, King BA
    JAK inhibitors in dermatology: The promise of a new drug class.
    J Am Acad Dermatol. 2017;76:736-744.
    PubMed     Text format     Abstract available


    March 2017
  51. MOHAMMAD AA, Wu SZ, Ibrahim O, Bena J, et al
    Prevalence of atopic comorbidities in eosinophilic esophagitis: A case-control study of 449 patients.
    J Am Acad Dermatol. 2017;76:559-560.
    PubMed     Text format    


    February 2017
  52. BROWN G, Wang E, Leon A, Huynh M, et al
    Tumor necrosis factor-alpha inhibitor-induced psoriasis: Systematic review of clinical features, histopathological findings, and management experience.
    J Am Acad Dermatol. 2017;76:334-341.
    PubMed     Text format     Abstract available


    January 2017
  53. KIM M, Choi KH, Hwang SW, Lee YB, et al
    Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: A population-based cross-sectional study.
    J Am Acad Dermatol. 2017;76:40-48.
    PubMed     Text format     Abstract available


  54. LEE HY, Fook-Chong S, Koh HY, Thirumoorthy T, et al
    Cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis: Retrospective analysis of a cohort treated in a specialized referral center.
    J Am Acad Dermatol. 2017;76:106-113.
    PubMed     Text format     Abstract available


    December 2016
  55. SAUDER MB, McEvoy A, Ramien ML
    Prescribing success: Developing an integrated prescription and eczema action plan for atopic dermatitis.
    J Am Acad Dermatol. 2016;75:1281-1283.
    PubMed     Text format    


  56. VAN DER SCHAFT J, Ariens LF, Bruijnzeel-Koomen CA, de Bruin-Weller MS, et al
    Serum vitamin D status in adult patients with atopic dermatitis: Recommendations for daily practice.
    J Am Acad Dermatol. 2016;75:1257-1259.
    PubMed     Text format    


    November 2016
  57. TOTRI CR, Eichenfield LF, Logan K, Proudfoot L, et al
    Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
    J Am Acad Dermatol. 2016 Nov 14. pii: S0190-9622(16)30832.
    PubMed     Text format     Abstract available


  58. FARAHNIK B, Beroukhim K, Danesh M, Nakamura M, et al
    Successful use of a modified Goeckerman regimen in the treatment of chronic severe atopic dermatitis: A prospective pilot study.
    J Am Acad Dermatol. 2016;75:1068-1071.
    PubMed     Text format    


  59. FARAHNIK B, Kwong B, Murase J
    General management strategy for epidermal growth factor receptor inhibitor-associated papulopustular eruption.
    J Am Acad Dermatol. 2016;75:e191.
    PubMed     Text format    


  60. DEZA G, Brasileiro A, Bertolin-Colilla M, Curto-Barredo L, et al
    Acquired cold urticaria: Clinical features, particular phenotypes, and disease course in a tertiary care center cohort.
    J Am Acad Dermatol. 2016;75:918-924.
    PubMed     Text format     Abstract available


  61. PERRY BM, Nguyen A, Desmond BL, Blattner CM, et al
    Eruptive nevi associated with medications (ENAMs).
    J Am Acad Dermatol. 2016;75:1045-1052.
    PubMed     Text format     Abstract available


    October 2016
  62. WEISS D, Schaschinger M, Ristl R, Gruber R, et al
    Ustekinumab treatment in severe atopic dermatitis: Down-regulation of T-helper 2/22 expression.
    J Am Acad Dermatol. 2016 Oct 13. pii: S0190-9622(16)30599.
    PubMed     Text format     Abstract available


  63. ANDERSEN YM, Egeberg A, Gislason GH, Skov L, et al
    Autoimmune diseases in adults with atopic dermatitis.
    J Am Acad Dermatol. 2016 Oct 11. pii: S0190-9622(16)30734.
    PubMed     Text format     Abstract available


  64. EGEBERG A, Skov L, Andersen YM, Mallbris L, et al
    Ten-year mortality is increased after hospitalization for atopic dermatitis compared with the general population, but reduced compared with psoriasis.
    J Am Acad Dermatol. 2016 Oct 11. pii: S0190-9622(16)30399.
    PubMed     Text format     Abstract available


    September 2016
  65. HILL MK, Kheirandish Pishkenari A, Braunberger TL, Armstrong AW, et al
    Recent trends in disease severity and quality of life instruments for patients with atopic dermatitis: A systematic review.
    J Am Acad Dermatol. 2016 Sep 8. pii: S0190-9622(16)30474.
    PubMed     Text format     Abstract available


  66. HAN B, Wu WH, Bae JM, Son SJ, et al
    Serum leptin and adiponectin levels in atopic dermatitis (AD) and their relation to disease severity.
    J Am Acad Dermatol. 2016;75:629-31.
    PubMed     Text format    


  67. GONZALEZ ME, Schaffer JV, Orlow SJ, Gao Z, et al
    Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis.
    J Am Acad Dermatol. 2016;75:481-493.
    PubMed     Text format     Abstract available


    August 2016
  68. KIM JP, Chao LX, Simpson EL, Silverberg JI, et al
    Persistence of atopic dermatitis (AD): A systematic review and meta-analysis.
    J Am Acad Dermatol. 2016 Aug 17. pii: S0190-9622(16)30309.
    PubMed     Text format     Abstract available


  69. KANTOR R, Kim A, Thyssen J, Silverberg JI, et al
    Association of atopic dermatitis with smoking: A systematic review and meta-analysis.
    J Am Acad Dermatol. 2016 Aug 16. pii: S0190-9622(16)30495.
    PubMed     Text format     Abstract available


  70. BARBAROT S, Rogers NK, Abuabara K, Aubert H, et al
    Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review.
    J Am Acad Dermatol. 2016 Aug 10. pii: S0190-9622(16)30325.
    PubMed     Text format     Abstract available


  71. MINKIS K, Whittington A, Alam M
    Dermatologic surgery emergencies: Complications caused by systemic reactions, high-energy systems, and trauma.
    J Am Acad Dermatol. 2016;75:265-84.
    PubMed     Text format     Abstract available


    July 2016
  72. HANIFIN JM
    New drugs for atopic dermatitis may provide clues to basic mechanisms of itch and inflammation.
    J Am Acad Dermatol. 2016 Jul 7. pii: S0190-9622(16)30390.
    PubMed     Text format    


  73. PALLER AS, Tom WL, Lebwohl MG, Blumenthal RL, et al
    Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.
    J Am Acad Dermatol. 2016 Jul 7. pii: S0190-9622(16)30330.
    PubMed     Text format     Abstract available


  74. WEI EX, Kirsner RS, Eaglstein WH
    End points in dermatologic clinical trials: A review for clinicians.
    J Am Acad Dermatol. 2016;75:203-9.
    PubMed     Text format     Abstract available


    June 2016
  75. KOHLI N, Nedorost S
    Inflamed skin predisposes to sensitization to less potent allergens.
    J Am Acad Dermatol. 2016 Jun 8. pii: S0190-9622(16)01548.
    PubMed     Text format     Abstract available


  76. SIMPSON EL, Gadkari A, Worm M, Soong W, et al
    Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD).
    J Am Acad Dermatol. 2016 Jun 4. pii: S0190-9622(16)30193.
    PubMed     Text format     Abstract available


  77. CHEN YC, Rosenblum MD, Shinkai K
    Plasmacytoid dendritic cells (pDCs) and regulatory T (Treg) cells may be the key to viral reactivation in drug-induced hypersensitivity syndrome (DIHS).
    J Am Acad Dermatol. 2016;74:1288-9.
    PubMed     Text format    


  78. MOWAD CM, Anderson B, Scheinman P, Pootongkam S, et al
    Allergic contact dermatitis: Patient management and education.
    J Am Acad Dermatol. 2016;74:1043-54.
    PubMed     Text format     Abstract available


  79. MOWAD CM, Anderson B, Scheinman P, Pootongkam S, et al
    Allergic contact dermatitis: Patient diagnosis and evaluation.
    J Am Acad Dermatol. 2016;74:1029-40.
    PubMed     Text format     Abstract available


  80. CLARK JJ, Secrest AM, Hull CM, Eliason MJ, et al
    The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart review.
    J Am Acad Dermatol. 2016;74:1274-6.
    PubMed     Text format    


  81. FAIVRE C, Villani AP, Aubin F, Lipsker D, et al
    Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.
    J Am Acad Dermatol. 2016;74:1153-9.
    PubMed     Text format     Abstract available


  82. MOON AT, Castelo-Soccio L, Yan AC
    Emergency department utilization of pediatric dermatology (PD) consultations.
    J Am Acad Dermatol. 2016;74:1173-7.
    PubMed     Text format     Abstract available


    May 2016
  83. KOHN LL, Kang Y, Antaya RJ
    A randomized, controlled trial comparing topical steroid application to wet versus dry skin in children with atopic dermatitis (AD).
    J Am Acad Dermatol. 2016 May 31. pii: S0190-9622(16)30199.
    PubMed     Text format     Abstract available


  84. HANIFIN JM, Ellis CN, Frieden IJ, Folster-Holst R, et al
    OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study.
    J Am Acad Dermatol. 2016 May 14. pii: S0190-9622(16)30025.
    PubMed     Text format     Abstract available


  85. BROEDERS JA, Ahmed Ali U, Fischer G
    Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience.
    J Am Acad Dermatol. 2016 May 11. pii: S0190-9622(16)01495.
    PubMed     Text format     Abstract available


    March 2016
  86. AUBIN F, Avenel-Audran M, Jeanmougin M, Adamski H, et al
    Omalizumab in patients with severe and refractory solar urticaria: A phase II multicentric study.
    J Am Acad Dermatol. 2016;74:574-5.
    PubMed     Text format    


    February 2016
  87. ERRICHETTI E, Pegolo E, Stinco G
    Dermoscopy as an auxiliary tool in the early differential diagnosis of acute generalized exanthematous pustulosis (AGEP) and exanthematous (morbilliform) drug eruption.
    J Am Acad Dermatol. 2016;74:e29-31.
    PubMed     Text format    


  88. CURTIS JA, Christensen LC, Paine AR, Collins Brummer G, et al
    Stevens-Johnson syndrome and toxic epidermal necrolysis treatments: An Internet survey.
    J Am Acad Dermatol. 2016;74:379-80.
    PubMed     Text format    


  89. PASCOE VL, Fenves AZ, Wofford J, Jackson JM, et al
    The spectrum of nephrocutaneous diseases and associations: Inflammatory and medication-related nephrocutaneous associations.
    J Am Acad Dermatol. 2016;74:247-70.
    PubMed     Text format     Abstract available


    January 2016
  90. HWANG SJ, Carlos G, Wakade D, Byth K, et al
    Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort.
    J Am Acad Dermatol. 2016 Jan 12. pii: S0190-9622(15)02387.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: